Cancer
Neoplasm of Uncertain Histogenesis
CI-CAN-00000034Explore in graph →
Non-malignant20,280 active trials259 approved drugs3,813 evidence items
Loading cancer entity…
Cancer
CI-CAN-00000034Explore in graph →
Clinical trials
91,351 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT00114764 | Trial Comparing Pegfilgrastim With Filgrastim as an Adjunct to Chemotherapy for Acute Myeloid Leukaemia (AML) | completed | Phase 2 | 84 | AmgenINDUSTRY | 0 | Oct 31, 2008 | clinicaltrials |
| NCT00189332 | Use of 852A in Metastatic Cutaneous Melanoma. | completed | Phase 2 | 28 | PfizerINDUSTRY | 3 | Oct 27, 2008 | clinicaltrials |
| NCT00204659 |
| Phase II Study With Rituximab and Cyclophosphamide, Doxorubicin, Vincristine, Prednisone (CHOP) in Patients With Gastric Diffuse Large B-Cell Non-Hodgkin's Lymphoma |
| completed |
| Phase 2 |
| 30 |
| University Hospital TuebingenOTHER |
| 1 |
| Oct 20, 2008 |
| clinicaltrials |
| NCT00092001 | Study Of SU011248 In Patients With Metastatic Non-Small Cell Lung Cancer | completed | Phase 2 | 111 | PfizerINDUSTRY | 3 | Oct 16, 2008 | clinicaltrials |
| NCT00246974 | Phase II Gemcitabine + Cisplatin +/- Iressa Bladder CCT | completed | Phase 2 | 125 | AstraZenecaINDUSTRY | 1 | Oct 15, 2008 | clinicaltrials |
| NCT00770393 | Laryngeal Preservation in Pyriform Sinus Carcinoma | completed | Phase 2 / Phase 3 | 71 | Centre Hospitalier Universitaire de Saint EtienneOTHER | 1 | Oct 10, 2008 | clinicaltrials |
| NCT00001144 | Modified Bone Marrow Stem Cell Transplantation for Chronic Myelogenous Leukemia | completed | Phase 2 | 50 | National Heart, Lung, and Blood Institute (NHLBI)NIH | 1 | Oct 7, 2008 | clinicaltrials |
| NCT00759226 | Chemotherapeutic Trial With Gemcitabine, Cisplatin, 5-FU and Folinic Acid in Esophageal Cancer(CONKO-101) | completed | Phase 2 | 92 | CONKO-StudiengruppeOTHER | 1 | Sep 26, 2008 | clinicaltrials |
| NCT00425204 | Study for Patients Who Have Benefited and Tolerated Prior Panitumumab Treatment | completed | Phase 2 | 31 | AmgenINDUSTRY | 0 | Sep 15, 2008 | clinicaltrials |
| NCT00290004 | Study of Weekly Motexafin Gadolinium (MGd) for Patients With Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma | completed | Phase 1 / Phase 2 | 35 | Pharmacyclics LLC.INDUSTRY | 1 | Sep 11, 2008 | clinicaltrials |
| NCT00350961 | Gemcitabine, Oxaliplatin and Capecitabine in Patients With Advanced Cholangiocarcinoma | completed | Phase 1 / Phase 2 | 39 | Rigshospitalet, DenmarkOTHER | 1 | Aug 26, 2008 | clinicaltrials |
| NCT00235898 | Clinical Trial in Patients With Metastatic Colorectal Cancer | completed | Phase 2 | 300 | Mast Therapeutics, Inc.INDUSTRY | 5 | Aug 25, 2008 | clinicaltrials |
| NCT00251485 | A Phase II Trial of Modified FOLFOX 6 and Cetuximab in First Line Treatment of Metastatic Colorectal Cancer | completed | Phase 2 | 82 | Veeda OncologyOTHER | 1 | Aug 21, 2008 | clinicaltrials |
| NCT00251498 | Phase II Study of Cetuximab in Combination With Carboplatin and Docetaxel for Patients With Advanced Non-Small Cell Lung Cancer | completed | Phase 2 | 82 | Veeda OncologyOTHER | 1 | Aug 21, 2008 | clinicaltrials |
| NCT00129844 | Study of Motexafin Gadolinium (MGd) for Second Line Treatment of Non-Small-Cell Lung Cancer | completed | Phase 2 | 108 | Pharmacyclics LLC.INDUSTRY | 2 | Aug 20, 2008 | clinicaltrials |
| NCT00346684 | Rituximab in Primary Lymphocyte Predominant Hodgkin´s Disease(RIPL) | completed | Phase 2 | — | University of CologneOTHER | 1 | Aug 12, 2008 | clinicaltrials |
| NCT00099970 | Volociximab in Combination With DTIC in Patients With Metastatic Melanoma Not Previously Treated With Chemotherapy | completed | Phase 2 | 40 | PDL BioPharma, Inc.INDUSTRY | 1 | Aug 5, 2008 | clinicaltrials |
| NCT00154739 | Gemcitabine/Cisplatin Versus Gemcitabine/Epirubicin for Non-Small Cell Lung Cancer (NSCLC) | completed | Phase 2 | 86 | National Taiwan University HospitalOTHER | 1 | Aug 4, 2008 | clinicaltrials |
| NCT00115414 | Same Day Dosing of Pegfilgrastim in Breast Cancer Patients Undergoing Chemotherapy (TAC) | completed | Phase 2 | — | AmgenINDUSTRY | 0 | Aug 1, 2008 | clinicaltrials |
| NCT00005880 | Budesonide in Treating Former and Current Smokers With Bronchial Dysplasia | completed | Phase 2 | — | British Columbia Cancer AgencyOTHER | 1 | Jul 24, 2008 | clinicaltrials |
| NCT00056693 | Treatment With SU11248 in Patients With Neuroendocrine Tumors | completed | Phase 2 | 107 | PfizerINDUSTRY | 1 | Jul 21, 2008 | clinicaltrials |
| NCT00428896 | A Feasibility Study With Iressa in Resistant Cytokeratin-Positive Tumor Cells Circulating in the Blood of Women With Breast Cancer | completed | Phase 2 | 24 | University Hospital of CreteOTHER | 1 | Jul 21, 2008 | clinicaltrials |
| NCT00217815 | Preliminary Study of Mycograb and Docetaxel in Advanced Breast Cancer | completed | Phase 1 / Phase 2 | 20 | NeuTec PharmaINDUSTRY | 2 | Jul 15, 2008 | clinicaltrials |
| NCT00422786 | Phase II Study of CAP-232 in Patients With Refractory Metastatic Renal Cell Carcinoma | completed | Phase 2 | 10 | Thallion PharmaceuticalsINDUSTRY | 1 | Jul 15, 2008 | clinicaltrials |
| NCT00222469 | Combination Chemotherapy for 1st Line Treatment of Advanced or Metastatic Pancreatic Cancer | completed | Phase 2 | 50 | University of OklahomaOTHER | 1 | Jul 9, 2008 | clinicaltrials |
| NCT00600977 | Liposomal Anthracyclin in the Treatment of Elderly ALL | completed | Phase 2 | 60 | French Innovative Leukemia OrganisationOTHER | 1 | Jun 26, 2008 | clinicaltrials |
| NCT00196885 | Effect of an Antioxidant on Cancer-Cachectic Patients Undergoing Exercise Training | completed | Phase 2 | 60 | German Cancer Research CenterOTHER | 1 | Jun 20, 2008 | clinicaltrials |
| NCT00697814 | Clomiphene in Males With Prolactinomas and Persistent Hypogonadism | completed | Phase 2 | 15 | Federal University of São PauloOTHER | 1 | Jun 16, 2008 | clinicaltrials |
| NCT00093002 | Fulvestrant (FASLODEX™) as a Treatment in Postmenopausal Women With Estrogen Receptor Positive Breast Cancer | completed | Phase 2 | 179 | AstraZenecaINDUSTRY | 6 | Jun 12, 2008 | clinicaltrials |
| NCT00212082 | Gene Expression Profiles in Predicting Chemotherapy Response in Breast Cancer | completed | Phase 2 | 100 | National University Hospital, SingaporeOTHER | 1 | Jun 12, 2008 | clinicaltrials |
| NCT00298688 | A Study of IRESSA in Relapsed and Refractory Small Cell Lung Cancer | completed | Phase 2 | 56 | AstraZenecaINDUSTRY | 2 | Jun 12, 2008 | clinicaltrials |
| NCT00696579 | Bacillus of Calmette and Guerin (BCG) Versus Gemcitabine For Intravesical Therapy In High Risk Superficial Bladder Cancer | completed | Phase 1 / Phase 2 | 64 | University Of PerugiaOTHER | 1 | Jun 12, 2008 | clinicaltrials |
| NCT00017680 | Study of High-Dose Melphalan and Autologous Stem Cell Transplantation in Patients With Primary Light Chain Amyloidosis | completed | Phase 2 | 25 | Herbert Irving Comprehensive Cancer CenterOTHER | 1 | Jun 9, 2008 | clinicaltrials |
| NCT00690703 | Radiofrequency Ablation of Pulmonary Tumors Response Evaluation(RAPTURE) | completed | Phase 2 | 106 | Angiodynamics, Inc.INDUSTRY | 5 | Jun 5, 2008 | clinicaltrials |
| NCT00139243 | Study of Taxotere, Cisplatin, 5-Fluorouracil, and Leucovorin for Squamous Cell Carcinoma of the Head and Neck | completed | Phase 1 / Phase 2 | 30 | Dana-Farber Cancer InstituteOTHER | 1 | Jun 4, 2008 | clinicaltrials |
| NCT00139269 | Study of Docetaxel in Combination With Cisplatin and 5-Fluorouracil in Locally Advanced Squamous Cell Carcinoma of the Head and Neck | completed | Phase 1 / Phase 2 | 38 | Dana-Farber Cancer InstituteOTHER | 0 | Jun 4, 2008 | clinicaltrials |
| NCT00187031 | A Phase II Study of Topotecan in Children With Recurrent Wilms Tumor | completed | Phase 2 | 37 | St. Jude Children's Research HospitalOTHER | 2 | Jun 4, 2008 | clinicaltrials |
| NCT00187161 | Treatment of Burkitt Lymphoma/Leukemia and B Large Cell NHL | completed | Phase 2 | 68 | St. Jude Children's Research HospitalOTHER | 1 | Jun 4, 2008 | clinicaltrials |
| NCT00135135 | Therapy for Children With Neuroblastoma | completed | Phase 2 | 23 | St. Jude Children's Research HospitalOTHER | 1 | Jun 3, 2008 | clinicaltrials |
| NCT00139230 | Combination Chemotherapy for Locally Advanced Squamous Cell Carcinoma of the Head and Neck | completed | Phase 2 | 30 | Dana-Farber Cancer InstituteOTHER | 1 | Jun 3, 2008 | clinicaltrials |
| NCT00150644 | A Study to Evaluate the Effects of Asoprisnil(J867) in Women With Uterine Fibroids Who Are Scheduled for a Hysterectomy | completed | Phase 2 | 33 | AbbottINDUSTRY | 0 | May 29, 2008 | clinicaltrials |
| NCT00177554 | Phase II Trial of CHOP-R Followed by Zevalin and Rituxan in Follicular Lymphoma | completed | Phase 2 | 60 | University of PittsburghOTHER | 1 | May 29, 2008 | clinicaltrials |
| NCT00284817 | Phase I Study of MEDI522 in Patients With Irinotecan-Refractory Advanced Colorectal Cancer | completed | Phase 1 / Phase 2 | 17 | MedImmune LLCINDUSTRY | 1 | May 29, 2008 | clinicaltrials |
| NCT00217282 | Study of Oxaliplatin and Gemcitabine With or Without Bevacizumab to Treat Advanced Non-Small Cell Lung Cancer | completed | Phase 2 | 45 | Mt. Sinai Medical Center, MiamiOTHER | 1 | May 22, 2008 | clinicaltrials |
| NCT00675194 | Efficacy of Irinotecan and Capecitabine Versus(vs) Cisplatin and Capecitabine in Patients With Esophago-Gastric Cancer | completed | Phase 2 | 120 | Johannes Gutenberg University MainzOTHER | 1 | May 20, 2008 | clinicaltrials |
| NCT00176813 | Gemcitabine, Cisplatin, and Celecoxib Treatment of Metastatic Pancreatic Cancer | completed | Phase 2 | 5 | University of Michigan Rogel Cancer CenterOTHER | 1 | May 6, 2008 | clinicaltrials |
| NCT00320476 | VTD Followed By MPT Maintenance As a First Line Treatment For The Patients With MM Who Are Non-Transplant Candidates | completed | Phase 2 | 35 | Korean Multiple Myeloma Working PartyOTHER | 1 | May 6, 2008 | clinicaltrials |
| NCT00087854 | Study of Individualized Amonafide to Treat Prostate Cancer | completed | Phase 1 / Phase 2 | 40 | Xanthus Pharmaceuticals, Inc.INDUSTRY | 1 | Apr 23, 2008 | clinicaltrials |
| NCT00064857 | Pycnogenol for the Treatment of Lymphedema of the Arm in Breast Cancer Survivors | completed | Phase 2 | 26 | National Center for Complementary and Integrative Health (NCCIH)NIH | 1 | Apr 22, 2008 | clinicaltrials |
Data updated 23 days agoSource updated Oct 31, 2008source: clinicaltrials